Back
Lonza Group Vs. NLS Pharmaceutics Industry Stock Comparison
Buy
62
LZAGY
Lonza Group
Last Price:
58.07
Seasonality Move:
9.12%
Sell
34
NLSP
NLS Pharmaceutics
Last Price:
0.14
Seasonality Move:
-32.49%
Buy
62
Lonza Group (LZAGY)
is a Buy
Is Lonza Group a Buy, Sell or Hold?
- The current Lonza Group [LZAGY] share price is $58.07. The Score for LZAGY is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- LZAGY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
NLS Pharmaceutics (NLSP)
is a Sell
Is NLS Pharmaceutics a Buy, Sell or Hold?
- The current NLS Pharmaceutics [NLSP] share price is $0.14. The Score for NLSP is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- NLSP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LZAGY Stock Price Chart
What is Lonza Group's stock price today?
-
The Lonza Group share price today is $58.07
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LZAGY is experiencing slight buying pressure.
NLSP Stock Price Chart
What is NLS Pharmaceutics's stock price today?
-
The NLS Pharmaceutics share price today is $0.14
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NLSP is experiencing buying pressure, which is a positive indicator for future bullish movement.
LZAGY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.2 | Buy |
Relative Strength Index (14 RSI): | 55.3 | Buy |
Chaikin Money Flow: | 1380 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (56 - 59.02) | Buy |
Bollinger Bands (100): | (44.98 - 58.02) | Buy |
NLSP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 38.04 | Sell |
Chaikin Money Flow: | 12281 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.13 - 0.15) | Sell |
Bollinger Bands (100): | (0.18 - 0.48) | Sell |
LZAGY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 57.24 | Buy |
20-day SMA: | 56.96 | Buy |
50-day SMA: | 56.72 | Buy |
200-day SMA: | 48.71 | Buy |
8-day EMA: | 57.52 | Buy |
20-day EMA: | 57.3 | Buy |
50-day EMA: | 55.92 | Buy |
200-day EMA: | 51.85 | Buy |
NLSP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.14 | Buy |
20-day SMA: | 0.14 | Buy |
50-day SMA: | 0.2 | Sell |
200-day SMA: | 0.53 | Sell |
8-day EMA: | 0.14 | Buy |
20-day EMA: | 0.14 | Sell |
50-day EMA: | 0.2 | Sell |
200-day EMA: | 0.49 | Sell |
Lonza Group Earnings Growth & LZAGY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NLS Pharmaceutics Earnings Growth & NLSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Lonza Group Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NLS Pharmaceutics Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |